Granules India Ltd SHARE PRICE [LIVE]

  
NSE
345.35
BSE
345.25
To view real time prices Login to your account
OPEN YOUR FREE DEMAT ACCOUNT AND START TRADING SEAMLESSLY
Already an existing customer? - Login Now!
NSE
BSE Click here to view BSE data
Live Chart
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Open:
High:
Low:
MKT Cap:
52-wk High:
52-wk Low:
Prev close:
P/E:
Div yield:

Fundamental analysis

Quality
Valuation
0 250 500 750 1 000
Financial trend

What is not working for the company?

What is working for the company?

Stock
Sector
Sensex
Name Mar 21 Dec 20

Similar Stocks

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made LUMPSUM investment of ₹ 1,00,000

in Granules India Ltd

Months ago

My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %

GRANULES News

Frequently Asked Questions

What is the Share price of GRANULES INDIA LTD. (GRANULES)?

GRANULES INDIA LTD. (GRANULES) share price as of September 30, 2022, on NSE is Rs 345.35 (NSE) and Rs 345.25 (BSE) on BSE.

Can I buy GRANULES INDIA LTD. (GRANULES) shares?

Yes, You can buy GRANULES INDIA LTD. (GRANULES) shares by opening a Demat account with Angel One.

How do I buy GRANULES INDIA LTD. (GRANULES) from Angel One?

GRANULES INDIA LTD. (GRANULES) share can be brought through the following modes:
  1. Direct investment: You can buy GRANULES INDIA LTD. (GRANULES) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to GRANULES INDIA LTD. (GRANULES) shares.

In which sector do GRANULES INDIA LTD. (GRANULES) belong?

GRANULES INDIA LTD. (GRANULES) belongs to Pharma.

About GRANULES

Today's live share price for Granules India Ltd is NSE: ₹ 345.35, BSE: ₹ 345.25 with a current market capitalization of .

Incorporated as a private limited company in 1991, Granules India (GIL) was converted into a public limited company in Feb.'93. It commenced its operations in Apr.'91 as a merchant exporter of bulk drugs like paracetamol, guaifenesin and chloro pheniramine maleate. The company exports to the US, Europe, Mexico and Hongkong. Since 1992, GIL concentrated on export of paracetamol powder. In Aug.'94, GIL took over Triton Laboratories (TL), a group company from which GIL was procuring the drugs for exports. GIL also acquired a sick unit which was manufacturing bulk drugs, from the Andhra Pradesh State Financial Corporation (APSFC) in Mar.'94. GIL implemented the ongoing project taken over from TL to manufacture bulk drugs like folic acid, salbutamol sulphate, brom pheniramine maleate and direct compression (DC) blends of paracetamol, through the process of granulation. The unit, an EOU, is located at Hyderabad, Andhra Pradesh. Commercial production of folic acid commenced in Aug.'95. It came out with a public issue in Sep.'95 to part-finance this project. Company has completed expansion of Guaifenesin capacity from 100 Mts to 240 Mts per annum. Company had developing new products like Brom Pheniramine Maleate & Chloro Pheniramine Maleate, & is in process of developing new bulk drug for the export market. Company is very much hopeful about company's performance due to expansion of project will be completed in the current year. The Company set up a 100% marketing subsidiary in US to enhance its exposure in the large pharmaceutical market in the world. The Gagillapur plant commences its commercial production of Line II(installed capacity 3200 MT) which was commenced its July,2003 and the remaining 4000 MTPA is expected to go on stream in the first half of 2003-04. The total project cost is Rs.30 crore.

Read more

Enjoy Zero Brokerage on Equity Delivery

Join our 1 Cr+ happy customers